Skip to main content
. Author manuscript; available in PMC: 2019 Dec 21.
Published in final edited form as: J Addict Dis. 2018 Dec 21;37(1-2):1–4. doi: 10.1080/10550887.2018.1531738

Table 1.

Logistic Regression Models Predicting Re-Arrest by 3 Month Follow-Up among Opioid-involved Women Incarcerated in Rural Jails

Bivariate Models No Re-arrest
N=133
n (%)
Re-arrest N=39
n (%)
Odds
Ratio
95% CI
Demographics
Age                       mean
(SD)
33.8 (8.8) 30.5 (7.4) 0.95 0.91, 0.99
Health insurance coverage, past 90 days at baseline 102 (76.7%) 31 (23.3%) 1.18 0.49, 2.83
Health problem interference, past 90 days at baseline 46 (83.6%) 9 (16.4%) 0.58 0.25, 1.30
Days incarcerated, at baseline           mean
(SD)
62.3 (65.7) 55.8 (69.2) 1.00 0.99, 1.00
County of incarceration, at baseline
                          Leslie
41 (74.5%) 14 (25.5%) ref
Laurel 46 (76.7%) 14 (23.3%) 1.27 0.52, 3.10
Perry 46 (80.7%) 11 (19.3%) 1.43 0.58, 3.50
Intervention assignment
NIDA Standard 64 (74.4%) 22 (25.6%) ref
NIDA Standard + MI 69 (80.2%) 17 (19.8%) 0.72 0.35, 1.47
Substance Use
ASSIST street opioid score, at baseline
                    mean(SD)
12.5 (15.6) 12.3 (15.5) 1.00 0.98, 1.02
ASSIST prescription opioid score, at baseline
                    mean(SD)
31.2 (10.4) 29.9 (10.8) 0.99 0.96, 1.02
Any drug injection, at follow-up 22 (16.5%) 16 (41.0%) 3.51 1.60, 7.70
Days high, at follow-up          mean
(SD)
14.9 (30.3) 37.3 (41.1) 1.02 1.01, 1.03
Illicit buprenorphine days, at follow-up   mean (SD) 9.2 (24.7) 21.9 (35.4) 1.01 1.003, 1.03
Substance-related problems
Drug overdose, at follow-up 0 (0.0%) 1 (2.6%) ------- --------
Withdrawal symptoms, at follow-up 20 (60.6%) 13 (39.4%) 2.83 1.25, 6.40
Services availability
Healthcare facilities available1, at follow-up
                   mean(SD)
7.5 (2.1) 6.8 (2.6) 0.96 0.84, 1.11
Drug treatment available2, at follow-up
mean(SD)
0.83 (1.19) 0.77 (1.31) 1.20 0.94, 1.53
Services use
Regular source of healthcare, at follow-up 65 (89.0%) 8 (11.0%) 0.27 0.12, 0.63
Ever prescribed buprenorphine, at baseline 33 (73.3%) 12 (26.7%) 1.35 0.61, 3.00
Substance treatment, at follow-up 31 (86.1%) 5 (13.9%) 0.48 0.17, 1.34
MAT, at follow-up 9 (100.0%) 0 (00.0%) -------- ---------
Multivariate Model3
 Intervention assignment 0.75 0.34,1.67
 County of incarceration               Laurel 0.69 0.23, 2.02
Perry 1.04 0.40, 2.69
 Age 0.97 0.92, 1.02
 Any drug injection 1.06 0.32, 3.57
 Days high 1.01 1.00, 1.03
 Illicit buprenorphine days 1.01 0.99, 1.02
 Withdrawal symptoms 1.93 0.58, 6.41
 Regular source of healthcare 0.22 0.08, 0.61

Notes:

1

Range 0–10;

2

Range 0–3;

3

Adjusted Odds Ratios, controlling for county and intervention group assignment.